ArticleScientific reports2024

Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy.

Mikhail Kostinov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.